ANTARES PHARMA INC (ATRS) Stock Analyst Earnings Estimates
NASDAQ:ATRS - Nasdaq - US0366421065 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 123.9M 94.81% | 149.6M 20.74% | 183.98M 22.98% | 214.619M 16.65% | 260.606M 21.43% | 303.458M 16.44% | 353.842M 16.60% | 420.843M 18.94% | |
| EBITDA YoY % growth | 3.56M 125.65% | 16.23M 355.90% | 31.24M 92.48% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 1M 106.02% | 13.6M 1,260.00% | 27.34M 101.03% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | 0.81% | 9.09% | 14.86% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 0.00 100.00% | 0.06 | 0.27 350.00% | 0.08 -69.78% | 0.22 172.91% | 0.34 54.81% | 0.72 109.67% | 1.55 113.86% |
| Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.01 -60.32% | 0.03 13.32% | 0.05 -75.84% | 0.03 355.00% | 0.04 199.91% | 0.06 80.02% | 0.07 44.44% |
| Revenue Q2Q % growth | 50.367M 11.98% | 58.053M 20.47% | 62.109M 27.46% | 57.936M 31.45% | 63.036M 25.15% | 68.136M 17.37% | 67.932M 9.38% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | -0.01 -150.00% | 0.00 | -0.01 | -394.41% |
| Q4 2021 Q2Q % growth | 0.19 533.33% | 0.01 | 0.18 | 1,297.41% |
| Q3 2021 Q2Q % growth | 0.03 | 0.03 | 0.00 | 14.40% |
| Q2 2021 Q2Q % growth | 0.03 200.00% | 0.02 | 0.01 | 66.07% |
| Q1 2021 Q2Q % growth | 0.02 300.00% | 0.01 | 0.01 | 96.08% |
| Q4 2020 Q2Q % growth | 0.03 | 0.04 | -0.01 | -15.97% |
| Q3 2020 Q2Q % growth | 0.03 200.00% | 0.02 | 0.01 | 26.07% |
| Q2 2020 Q2Q % growth | 0.01 200.00% | 0.00 | 0.01 | 394.41% |
| Q1 2020 Q2Q % growth | -0.01 66.67% | 0.00 | -0.01 | -390.20% |
| Q4 2019 Q2Q % growth | 0.03 | 0.00 | 0.03 | 783.24% |
| Q3 2019 Q2Q % growth | 0.01 | -0.02 | 0.03 | 149.02% |
| Q2 2019 Q2Q % growth | -0.01 | -0.04 | 0.03 | 74.86% |
| Q1 2019 Q2Q % growth | -0.03 | -0.04 | 0.01 | 26.16% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | 4.74% | 44.074M | % | |
| Q4 2021 Q2Q % growth | 48.73M 10.42% | 47.617M | 1.113M | 2.34% |
| Q3 2021 Q2Q % growth | 48.19M 20.47% | 49.297M | -1.107M | -2.25% |
| Q2 2021 Q2Q % growth | 44.98M 38.91% | 44.19M | 790.101K | 1.79% |
| Q1 2021 Q2Q % growth | 42.08M 27.21% | 39.237M | 2.843M | 7.25% |
| Q4 2020 Q2Q % growth | 44.13M 16.62% | 41.568M | 2.562M | 6.16% |
| Q3 2020 Q2Q % growth | 40M 16.58% | 36.383M | 3.617M | 9.94% |
| Q2 2020 Q2Q % growth | 32.38M 13.89% | 30.992M | 1.388M | 4.48% |
| Q1 2020 Q2Q % growth | 33.08M 42.04% | 32.574M | 505.617K | 1.55% |
| Q4 2019 Q2Q % growth | 37.84M | 32.925M | 4.915M | 14.93% |
| Q3 2019 Q2Q % growth | 34.31M | 27.431M | 6.879M | 25.08% |
| Q2 2019 Q2Q % growth | 28.43M | 22.943M | 5.487M | 23.92% |
| Q1 2019 Q2Q % growth | 23.29M | 18.539M | 4.751M | 25.62% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |